Compare UL & CI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | UL | CI |
|---|---|---|
| Founded | 1930 | 1792 |
| Country | United Kingdom | United States |
| Employees | 96092 | N/A |
| Industry | Package Goods/Cosmetics | Medical Specialities |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 125.1B | 79.0B |
| IPO Year | N/A | 2018 |
| Metric | UL | CI |
|---|---|---|
| Price | $60.60 | $282.11 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 15 |
| Target Price | N/A | ★ $349.00 |
| AVG Volume (30 Days) | ★ 4.1M | 1.4M |
| Earning Date | 03-12-2026 | 04-30-2026 |
| Dividend Yield | ★ 4.04% | 2.13% |
| EPS Growth | N/A | ★ 83.00 |
| EPS | N/A | ★ 6.26 |
| Revenue | N/A | ★ $274,900,000,000.00 |
| Revenue This Year | $2.53 | $5.91 |
| Revenue Next Year | $3.78 | $5.92 |
| P/E Ratio | ★ $14.29 | $45.03 |
| Revenue Growth | N/A | ★ 11.24 |
| 52 Week Low | $54.75 | $239.51 |
| 52 Week High | $74.98 | $338.89 |
| Indicator | UL | CI |
|---|---|---|
| Relative Strength Index (RSI) | 62.46 | 46.34 |
| Support Level | $60.16 | $280.76 |
| Resistance Level | $61.14 | $294.33 |
| Average True Range (ATR) | 0.78 | 6.25 |
| MACD | 0.36 | -1.16 |
| Stochastic Oscillator | 89.92 | 25.98 |
Unilever is a diversified beauty, wellbeing, and personal care (51% of 2025 sales by value), homecare (23%), and packaged food (26%) company. Its brands include Dove personal-care products, Knorr soups and sauces, Hellmann's mayonnaise, Axe and Rexona deodorants, and TRESemmé haircare. The firm has been acquisitive in recent years; notable purchases include Paula's Choice, Liquid I.V., Horlicks, and Wild deodorants. The company derives 58% of its sales from emerging markets and 42% from developed markets. The US is its largest market, accounting for around 20% of sales, followed by India, which accounts for 11% of sales.
Cigna primarily provides pharmacy benefit management and health insurance services. Its PBM and specialty pharmacy services, which were greatly expanded by its 2018 merger with Express Scripts, are mostly sold to health insurance plans and employers. Its largest PBM contract is with the Department of Defense, and it recently won a multiyear deal with top-tier insurer Centene. In health insurance and other benefits, Cigna primarily serves employers through self-funding arrangements, and the company operates mostly in the US with 16 million US and 2 million international medical members covered as of December 2025.